Paper28977902
ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.
Ni X and 7 others. Oncotarget, 2017. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways. Papers, record 28977902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28977902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30CA016672 | NIH |
Source NIH RePORTER
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23676217 | STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. | Cell Cycle | 2013 | https://conductscience.org/library/papers/23676217 | PubMed |
| 2 | 24226419 | The role of IL-32 in cutaneous T-cell lymphoma. | J Invest Dermatol | 2014 | https://conductscience.org/library/papers/24226419 | PubMed |
| 3 | 22892844 | Regulation of the human TRAIL gene. | Cancer Biol Ther | 2012 | https://conductscience.org/library/papers/22892844 | PubMed |
| 4 | 25139620 | Downregulation of endogenous STAT3 augments tumoricidal activity of interleukin 15 activated dendritic cell against lymphoma and leukemia via TRAIL. | Exp Cell Res | 2014 | https://conductscience.org/library/papers/25139620 | PubMed |
| 5 | 26438120 | Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26438120 | PubMed |
| 6 | 14996704 | T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance. | Blood | 2004 | https://conductscience.org/library/papers/14996704 | PubMed |
| 7 | 26884599 | ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies. | Sci Signal | 2016 | https://conductscience.org/library/papers/26884599 | PubMed |
| 8 | 9129044 | Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. | Blood | 1997 | https://conductscience.org/library/papers/9129044 | PubMed |
| 9 | 26551670 | Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. | Nat Genet | 2015 | https://conductscience.org/library/papers/26551670 | PubMed |
| 10 | 9192639 | Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9192639 | PubMed |
| 11 | 15618960 | Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. | Leukemia | 2005 | https://conductscience.org/library/papers/15618960 | PubMed |
| 12 | 25376389 | Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/25376389 | PubMed |
| 13 | 27602582 | Discovery and clinical introduction of first-in-class imipridone ONC201. | Oncotarget | 2016 | https://conductscience.org/library/papers/27602582 | PubMed |
| 14 | 18086343 | Mycosis fungoides: pathophysiology and emerging therapies. | Semin Oncol | 2007 | https://conductscience.org/library/papers/18086343 | PubMed |
| 15 | 15086538 | Genomic aberrations and survival in cutaneous T cell lymphomas. | J Invest Dermatol | 2004 | https://conductscience.org/library/papers/15086538 | PubMed |
| 16 | 27637428 | Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides. | Clin Lymphoma Myeloma Leuk | 2016 | https://conductscience.org/library/papers/27637428 | PubMed |
| 17 | 25681273 | Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10. | Cancer Res | 2015 | https://conductscience.org/library/papers/25681273 | PubMed |
| 18 | 26884600 | ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. | Sci Signal | 2016 | https://conductscience.org/library/papers/26884600 | PubMed |
| 19 | 21148039 | Negative regulation of IRF7 activation by activating transcription factor 4 suggests a cross-regulation between the IFN responses and the cellular integrated stress responses. | J Immunol | 2011 | https://conductscience.org/library/papers/21148039 | PubMed |
| 20 | 25485578 | Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. | Cell Cycle | 2014 | https://conductscience.org/library/papers/25485578 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42751161 | ONC201/dordaviprone for H3 K27M-mutant tumors: Discovery, mechanisms, therapeutic potential, and future directions. | Genes Dis | 2027 | https://conductscience.org/library/papers/42751161 | PubMed |
| 39302105 | Small-Molecule CCR4 Antagonists in Cutaneous T-cell Lymphoma. | Cancer Res Commun | 2024 | https://conductscience.org/library/papers/39302105 | PubMed |
| 39007268 | Targeting apoptotic pathways for cancer therapy. | J Clin Invest | 2024 | https://conductscience.org/library/papers/39007268 | PubMed |
| 38192653 | Role of interleukin‑32 in cancer progression (Review). | Oncol Lett | 2024 | https://conductscience.org/library/papers/38192653 | PubMed |
| 37830594 | New JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma. | Cells | 2023 | https://conductscience.org/library/papers/37830594 | PubMed |
| 37643767 | Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1. | Mol Cancer Ther | 2023 | https://conductscience.org/library/papers/37643767 | PubMed |
| 37046596 | Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37046596 | PubMed |
| 36555190 | ONC201-Induced Mitochondrial Dysfunction, Senescence-like Phenotype, and Sensitization of Cultured BT474 Human Breast Cancer Cells to TRAIL. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555190 | PubMed |
| 34948183 | Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948183 | PubMed |
| 34873466 | Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer. | Am J Cancer Res | 2021 | https://conductscience.org/library/papers/34873466 | PubMed |
| 34680295 | Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34680295 | PubMed |
| 34278852 | The Crosstalk Between Long Non-Coding RNAs and Various Types of Death in Cancer Cells. | Technol Cancer Res Treat | 2021 | https://conductscience.org/library/papers/34278852 | PubMed |
| 34088951 | Microarray analysis reveals ONC201 mediated differential mechanisms of CHOP gene regulation in metastatic and nonmetastatic colorectal cancer cells. | Sci Rep | 2021 | https://conductscience.org/library/papers/34088951 | PubMed |
| 33932119 | ONC201 induces the unfolded protein response (UPR) in high- and low-grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity. | Cancer Med | 2021 | https://conductscience.org/library/papers/33932119 | PubMed |
| 33336683 | Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells. | Neuro Oncol | 2021 | https://conductscience.org/library/papers/33336683 | PubMed |
| 33142238 | ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. | Neoplasia | 2020 | https://conductscience.org/library/papers/33142238 | PubMed |
| 32395722 | Targeting the PI3K/AKT/mTOR/NFκB Axis in Ovarian Cancer. | J Cell Immunol | 2020 | https://conductscience.org/library/papers/32395722 | PubMed |
| 31702782 | Biological activity of weekly ONC201 in adult recurrent glioblastoma patients. | Neuro Oncol | 2020 | https://conductscience.org/library/papers/31702782 | PubMed |
| 31236543 | Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1. | Immunohorizons | 2019 | https://conductscience.org/library/papers/31236543 | PubMed |
| 31021596 | Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues. | ACS Chem Biol | 2019 | https://conductscience.org/library/papers/31021596 | PubMed |
Genes48
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28977902
GET https://conductscience.org/api/papers/v1/28977902/references?page=2